Tag: biosimilars
Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now
Patent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
read morerecent posts
Generic and brand-name drugs have the same active ingredients, so their risk for drug interactions is essentially identical. Learn what really matters - and what doesn't - when switching medications.
Published ON: 2 FebLearn how to use naloxone nasal spray to reverse an opioid overdose in simple, step-by-step instructions. Includes signs of overdose, dosing, safety tips, and what to do after administration.
Published ON: 18 FebLearn how to read FDA safety communications about your medications. These updates can change how you take your drug, warn of new side effects, or tell you when to call your doctor. Don't ignore them.
Published ON: 19 FebHospitals choose generic drugs based on clinical safety, supply reliability, and real-world performance-not just price. Learn how Pharmacy and Therapeutics committees make these critical decisions under growing economic and regulatory pressure.
Published ON: 7 FebExplore how generic drug prices change yearly due to competition, regulations, and market dynamics. Learn why some generics spike in cost while others drop, and what this means for patients and healthcare.
Published ON: 6 Feb